STRATEC Biomedical's market cap is currently €354.35M. The company's EPS TTM is €0.09; its P/E ratio is 22.12; and it has a dividend yield of 2.06%. STRATEC Biomedical is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
